Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Diphtheria and tetanus toxoids and acellular pertussis |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
Diphtheria toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
Tetanus and diphtheria toxoid adsorbed for adult use |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
Vaccine product containing Clostridium tetani toxoid adsorbed and Corynebacterium diphtheriae toxoid antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
Tetanus toxoid, adsorbed 20u/mL 0.5mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
Administration of vaccine product containing only acellular Bordetella pertussis and Corynebacterium diphtheriae and Hepatitis B virus and inactivated whole Human poliovirus antigens (procedure) |
Direct substance |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
Diphtheria, acellular pertussis, hepatitis B and inactivated polio vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
Adsorbed diphtheria+tetanus+pertussis vaccine injection 7.5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
Tetanus toxoid, adsorbed 10unt intramuscular injection suspension 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
Tetanus toxoid, adsorbed 10unt intramuscular injection suspension 0.5mL syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
Adsorbed diphtheria+tetanus+pertussis vaccine injection 0.5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
Tetanus and diphtheria toxoid |
Is a |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
Tetanus toxoid/reduced diphtheria toxoid/acellular pertussis vaccine injection 0.5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
Tetanus and diphtheria toxoid |
Is a |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
Vaccine product containing Clostridium tetani toxoid adsorbed and Corynebacterium diphtheriae toxoid antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
1 |
Recombinant hepatitis B virus surface antigen 10micrograms/diphtheria toxoid 30 iu/tetanus toxoid 40 iu/acellular pertussis 25micrograms injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
Diphtheria toxoid 30 iu/tetanus toxoid 40 iu/acellular pertussis toxoid 25micrograms injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
Diphtheria toxoid 30 iu/tetanus toxoid 40 iu/acellular pertussis toxoid 25 micrograms/inactivated poliomyelitis 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
Diphtheria toxoid 30 iu/tetanus toxoid 40 iu/acellular pertussis 25micrograms/recombinant hepatitis B virus surface antigen 10micrograms/inactivated poliomyelitis injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
Tetanus toxoid/reduced diphtheria toxoid/acellular pertussis vaccine injection 0.5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
Diphtheria and tetanus toxoids and acellular pertussis |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
Tetanus and diphtheria toxoid adsorbed for adult use |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
Vaccine product containing whole cell Bordetella pertussis and Clostridium tetani toxoid adsorbed and Corynebacterium diphtheriae toxoid antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
1 |
Vaccine product containing only whole cell Bordetella pertussis and Clostridium tetani toxoid adsorbed and Corynebacterium diphtheriae toxoid antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
1 |
Vaccine product containing only Clostridium tetani toxoid adsorbed and Corynebacterium diphtheriae toxoid antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
1 |